Pretransplant serum hepatitis C virus RNA levels predict response to antiviral treatment after living donor liver transplantation.

<h4>Background</h4>Given the limited efficacy and high adverse event rate associated with treatment of recurrent hepatitis C after liver transplantation, an individualized treatment strategy should be considered. The aim of this study was to identify predictors of response to antiviral t...

Full description

Bibliographic Details
Main Authors: Yoshihide Ueda, Toshimi Kaido, Yasuhiro Ogura, Kohei Ogawa, Atsushi Yoshizawa, Koichiro Hata, Yasuhiro Fujimoto, Aya Miyagawa-Hayashino, Hironori Haga, Hiroyuki Marusawa, Satoshi Teramukai, Shinji Uemoto, Tsutomu Chiba
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2013-01-01
Series:PLoS ONE
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23505497/?tool=EBI